Clinical trial
Multi-institution, Randomized Trial for Efficacy and Safety of Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy for the Treatment of Uterine Myoma or Adenomyosis
NCT01483417 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-institution, Randomized Trial for Efficacy and Safety of Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy for the Treatment of Uterine Myoma or Adenomyosis
- Lead sponsor
- Samsung Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2011
- Completion date
- March 31, 2013
- Enrollment
- 240 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
uterine adenomyosis, uterine myoma